16 Nov 2023
Updates to the HTA Policy and Methods Review Reference Committee – 16 November 2023
Updates to the HTA Policy and Methods Review Reference Committee – 16 November 2023
10 Nov 2023
Updates to the HTA Review: Consultation 1 report published
Updates to the HTA Review: Consultation 1 report published
09 Nov 2023
Updates to the HTA Policy and Methods Review Reference Committee – 9 November 2023
Updates to the HTA Policy and Methods Review Reference Committee – 9 November 2023
06 Nov 2023
Updates to the HTA Policy and Methods Review Reference Committee – 3 November 2023
Updates to the HTA Policy and Methods Review Reference Committee – 3 November 2023
01 Nov 2023
PBS arrangements during shortage of amoxicillin and clavulanate potassium 400 mg/57 mg per 5 mL oral suspension effective 1 November 2023
Due to the shortage of Curam Duo (amoxicillin 400 mg/5 mL + clavulanic acid 57 mg/5 mL powder for oral liquid, 60 mL)
30 Oct 2023
Updates to the HTA Review Research and analysis papers collection: Draft HTA expert paper published - 30 October 2023
The draft paper International Health Technology Market Approval, Funding and Assessment Pathways developed to support the deliberations of the HTA Review Reference Committee, has been published on the HTA Review Research and Analysis papers webpage.
30 Oct 2023
Updated Agenda for November 2023 PBAC Meeting – 30 October 2023
Updated Agenda for November 2023 PBAC Meeting – 30 October 2023
30 Oct 2023
Expressions of Interest to join the Pharmaceutical Benefits Remuneration Tribunal
We are seeking expressions of interest to fill 3 vacancies on the Pharmaceutical Benefits Remuneration Tribunal (PBRT) that commence in May 2024. Consider applying if you have expertise in regulatory fields, competition research or legal practice relating to medicine and pharmacy.
27 Oct 2023
PBAC Public Summary Documents – July 2023 meeting
PBAC Public Summary Documents – July 2023 meeting